The board of directors of Lansen Pharmaceutical Holdings Limited announced that a nomination committee has been established by the Board with written terms of reference with effect from 23 March 2022. Members of the Nomination Committee shall comprise such directors of the Company appointed by the Board. The Board has appointed Mr. Wu Zhen Tao, the chairman of the Board, as the chairman of the Nomination Committee and Mr. Chan Kee Huen, Michael and Mr. Yeung Tak Bun, Allen, the independent non-executive directors of the Company, as members of the Nomination Committee, with effect from 23 March 2022.